Posted by ILADVOCATE on September 6, 2008, at 13:59:22
I am on glycine, 24 grams under the care of a psychopharmcologist and have obtained a full recovery. It is a new generation of antipsychotics in study, the glutamate antagonists. My psychiatrist is seeking to publish the results in a psychiatric journal. Glycine is available over the shelves but should only be taken under a psychiatrist's care. This generation of antipsychotics cannot cause tardive dyskinesia,which I have from the previous antipsychotics in severe forms including tardive psychosis which is also is study, weight gain, diabetes or extra pyramidal side effects and does not cause cognitive blunting but is actually helpful on cognitive and negative symptoms of schizophrenia. The only antipsychotic currently available that cannot cause tardive dyskinesia, which can be masked as it is occuring, is Clozaril and I could not tolerate its severe side effects. The current studies use glycine as an adjunct but my psychiatrist has obtained favorable results as a primary antipsychotic. This is part of a new generation of antipsychotics in study that have shown extremely favorable results and will eventually replace the current medications. There is a symposium on new medications in development that anyone reading this should consider attending to find out about new antipsychotics that are being studied:
http://www.narsad.org/help/campaign/publicannouncement.html
poster:ILADVOCATE
thread:850659
URL: http://www.dr-bob.org/babble/20080903/msgs/850659.html